Screener
Ligand Pharmaceuticals LGND Total Current Assets
Total Current Assets at other companies
Other financials
Where this comes from
Reported directly by Ligand Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:AssetsCurrent.
The source filing: Ligand Pharmaceuticals’s 10-Q, filed August 7, 2026.
- Filed
- Aug 7, 2026, 4:06 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000886163-26-000044
| Line item | June 30, 2026 | December 31, 2025 |
|---|---|---|
| Short-term portion of financial royalty assets, net | 12,982 | 22,792 |
| Income taxes receivable | 2,911 | 1,446 |
| Other current assets | 6,191 | 5,785 |
| Total current assets | 1,457,116 | 832,271 |
| Intangible assets, net | 209,244 | 225,438 |
| Goodwill | 101,541 | 101,541 |
| Long-term portion of financial royalty assets, net | 194,228 | 196,877 |
| Noncurrent derivative assets | 17,913 | 15,632 |
Item 1. Condensed Consolidated Financial Statements (unaudited)
FAQ
- What is Ligand Pharmaceuticals's total current assets?
- Ligand Pharmaceuticals (LGND) reported total current assets of $1.46B in Q2 2026.
- How has Ligand Pharmaceuticals's total current assets changed year-over-year?
- Ligand Pharmaceuticals's total current assets increased by 312.8% year-over-year, from $352.95M to $1.46B.
- What is the long-term trend for Ligand Pharmaceuticals's total current assets?
- Over 5 years (2020 to 2025), Ligand Pharmaceuticals's total current assets has grown at a 10.7% compound annual growth rate (CAGR), from $500.56M to $832.27M.
- What does total current assets mean?
- The sum of all assets expected to be converted to cash or consumed within one year — cash, receivables, inventory, and prepaid expenses.
Ask your AI about Ligand Pharmaceuticals's total current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude